You can catch up on all the latest news in breast cancer imaging and research in our Women’s Imaging Digital Community.
Dear Women's Imaging Insider,
Researchers at the University of Washington in Seattle believe they have found a simple, yet accurate, way to determine the success of neoadjuvant chemotherapy in women with locally advanced breast cancers.
Dr. David Mankoff, Ph.D., and colleagues used 15O- water PET scans to make a connection between tumor vascularity and chemotherapy resistance. More important, they found that the scans could be performed just two months into the treatment process, giving oncologists plenty of time to change the course of care, if necessary. To read more about this study, click here.
You can catch up on all the latest news in breast cancer imaging and research in our Women’s Imaging Digital Community. Other treatment-related articles include an Italian paper on the benefits of intraoperative radiation therapy, and an Australian study on the suboptimal use of radiotherapy, in breast cancer.
On the cancer risk front, a National Cancer Institute study found that the rates of large tumors among white women increased from 5.6 to 6.3 cases per 100,000 during the latter half of the century. Meanwhile, another government agency, the U.S. Preventive Services Task Force, suggested that biennial breast cancer screening for older women is cost- effective as long as they don’t have significant co-morbidities.
Finally, if breast imaging technology interests, check out an article on the pearls and pitfalls of adopting digital mammography.
